MH-Rx: Check-in on You, Your Medication, and Your Blood Pressure for Pregnant People

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares remote blood pressure monitoring with standard care to remote BP monitoring plus targeted CHW/SW support for non-medical needs and clinician-led medication management. All participants use a home BP kit and an app to track readings and participate in surveys about social needs, mood, and pregnancy care. The study will look at blood pressure control, maternal outcomes, feasibility, and participant satisfaction, with automated alerts for abnormal readings and tailored care plans. Safety measures include escalation for high PHQ-9 or GAD-7 scores and pathways for urgent concerns. Enrollment is for pregnant people up to 34 weeks with chronic or gestational hypertension who use a smartphone and can complete self-led assessments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female, pregnant ≤34 weeks
* Pregnancy Status: Pregnant, up to 34 weeks of gestation. Able to provide medical confirmation of pregnancy
* Age 18-45
* Diagnosis of chronic hypertension or Gestational Hypertension ( i.e: high blood pressure that was present before pregnancy or developed during pregnancy).
* Currently taking ≥1 medication
* Smartphone user
* Able to speak and read English
* Ability to participate in self-led surveys and perform remote blood pressure monitoring

Exclusion Criteria:

* Inability to Provide Legal Consent: Individuals who cannot legally consent to participate in the research study will be excluded.
* Availability Constraints: Individuals who are unavailable or unable to commit to the required study sessions and self-led surveys throughout the duration of their pregnancy and the 14-week postpartum follow-up period.
* Language Barrier: Individuals who do not speak and read English.
* Inability or Unwillingness to Provide Required Information: Individuals who are unable or unwilling to provide reliable contact information (phone, email, or address for app/text-based study communications), basic medical history needed to verify eligibility, or medical confirmation of pregnancy and gestational age (e.g., discharge summary, progress note, MyChart note, or signed medical release).

Where it's running

• Texas Southern University Nabrit Science Building, 3100 Cleburne St.
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Veronica Ajewole-Mwema, PharmD, BCOP — Texas Southern University
• Study coordinator: Veronica Ajewole-Mwema, PharmD, BCOP
• Email: veronica.ajewole@tsu.edu
• Phone: 713-313-1217

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood markers (sFlt-1/PlGF, sEng, OPG) for diagnosing and monitoring preeclampsia

  This study will test whether three blood markers—the sFlt-1/PlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)—can help diagnose and track preeclampsia in pregnant women between 20 and 36 weeks of gestation.

  Recruiting University of Thi-Qar · Nasiriyah, Dhi Qar · NCT07349277

• Atorvastatin after pregnancy to lower future heart disease risk

  This study will test whether taking atorvastatin for three months after stopping breastfeeding lowers future cardiovascular risk in people who had high blood pressure during pregnancy.

  Recruiting Phase 4 Ohio State University · Columbus, Ohio · NCT06632379

• Comparing two doses of aspirin to prevent pregnancy-related high blood pressure issues

  This study is testing if a higher dose of aspirin can better prevent high blood pressure problems during pregnancy for women at risk.

  Recruiting at 15 sites Phase 4 Ohio State University · Birmingham, Alabama and 19 other locations · NCT06468202

• Preeclampsia and normal pregnancy: retinal microcirculation using OCTA

  This study tests retinal blood flow in pregnant people with preeclampsia compared to healthy pregnant people using OCTA imaging.

  Recruiting Muğla Sıtkı Koçman University · Muğla, Menteşe · NCT07874191

• Community health worker support to lower blood pressure after pregnancy with high blood pressure

  Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07778966

• Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders

  This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728656

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.